—Mkt Cap: —P/E: —
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Cheaper
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value11.18M $
Revenue (TTM)14.81M $
Gross Profit11.86M $
Net Income (TTM)-4.31M $
Revenue/Share2.443 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees69
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINDE000A4BGGM7
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-16.24
EV/Revenue0.75
P/S1.03
P/B0.82
EPS (TTM)-1.09
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin82.71%
Oper. Margin0.24%
EBITDA Margin-4.65%
Profit Margin-30.06%
ROE-26.60%
ROA-19.21%
Growth
Revenue Growth13.40%
Earnings Growth227.30%
Cash Flow & Leverage
Operating CF-4.78M $
CapEx (TTM)55.43K $
FCF Margin—
FCF Yield—
Net Debt-4.07M $
Net Debt/EBITDA5.91
Balance Sheet
Debt/Equity0.00
Current Ratio2.96
Quick Ratio2.07
Book Value/Sh2.813 EUR
Cash/Share0.9280 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:21
Split DateMay 14, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.08M
Float1.40M
Insiders27.00%
Institutions0.00%
Technical
SMA 502.452 EUR
SMA 2002.573 EUR
Beta-0.23
S&P 52W Chg20.05%
Avg Vol (30d)—
Avg Vol (10d)1.25K
Technical Indicators
RSI (14)40.8
MACD-0.0439
MACD Signal-0.0237
MACD Hist.-0.0201
BB Upper2.695 EUR
BB Middle2.466 EUR
BB Lower2.238 EUR
BB Width18.54%
ATR (14)0.0989 EUR
Vol Ratio (20d)0.06x